Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway

被引：0
|
作者：
Shengqiang Zhao
Jing Wang
Chengyong Qin
机构：
[1] Shandong Provincial Hospital,Department of Gastroenterology
[2] Shandong University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Intrahepatic cholangiocarcinoma (IHCC); CXC chemokine ligand-12 (CXCL12)/chemokine receptor type 4 (CXCR4); Prognosis; Metastasis; Wnt pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Role of CXCL12/CXCR4 signaling axis in pancreatic cancer
    Wu Peng-fei
    Lu Zi-peng
    Cai Bao-bao
    Tian Lei
    Zou Chen
    Jiang Kui-rong
    Miao Yi
    CHINESE MEDICAL JOURNAL, 2013, 126 (17) : 3371 - 3374
  • [22] Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway
    Wang, Jia
    Cai, Jing
    Han, Fang
    Yang, Chun
    Tong, Qiaoling
    Cao, Ting
    Wu, Liying
    Wang, Zehua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 981 - 987
  • [23] Chemokine CXCL12 Activates CXC Receptor 4 Metastasis Signaling Through the Upregulation of a CXCL12/CXCR4/MDMX (MDM4) Axis
    Lee, Rusia
    Ellison, Viola
    Forbes, Dominique
    Gao, Chong
    Katanov, Diana
    Kern, Alexandra
    Levine, Fayola
    Leybengrub, Pam
    Ogunwobi, Olorunseun
    Xiao, Gu
    Feng, Zhaohui
    Bargonetti, Jill
    CANCERS, 2024, 16 (24)
  • [24] Blockade of CXCL12/CXCR4 Axis Ameliorates Murine Experimental Colitis
    Mikami, Sakae
    Nakase, Hiroshi
    Yamamoto, Shuji
    Takeda, Yasuhiro
    Yoshino, Takuya
    Kasahara, Katushiro
    Ueno, Satoru
    Uza, Norimitsu
    Oishi, Shinya
    Fujii, Nobutaka
    Nagasawa, Takashi
    Chiba, Tsutomu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02): : 383 - 392
  • [25] Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo
    Moore, N.
    Gonzales, M. Moreno
    Bonner, K.
    Smith, B.
    Park, W.
    Stegall, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (06) : 1663 - 1669
  • [26] Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo
    Bonner, K.
    Moore, N.
    Gonzales, M. Moreno
    Stegall, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 409 - 409
  • [27] Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo
    Moore, N.
    Gonzales, M. Moreno
    Stegall, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [28] CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy
    Abdulrahman Qais Khaleel
    Farag M. A. Altalbawy
    Majid S. Jabir
    Thikra F.Hasan
    Vicky Jain
    Vikrant Abbot
    Prashant Nakash
    M. Ravi Kumar
    Yasser Fakri Mustafa
    Mohammed Abed Jawad
    Medical Oncology, 42 (5)
  • [29] Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
    Xu, Dongsheng
    Li, Rongshi
    Wu, Jianguo
    Jiang, Li
    Zhong, Haizhen A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (13) : 1441 - 1451
  • [30] CXCL14, an inhibitor of CXCL12/CXCR4 signaling, is upregulated in prostate cancer bone metastasis.
    Dowell, Alexander
    Clines, Katrina
    Morrissey, Colm
    Wei, Shi
    Clines, Gregory
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S64 - S65
12345